v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Net loss $ (2,170,810) $ (2,809,741)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,622 6,477
Share-based compensation (42,996) 10,484
Rent expense (230) (1,379)
Change in fair value of derivative liabilities (301,803)
Accretion interest expense 9,684 42,312
Research and development costs for intangible assets 14,358 39,483
Gain on termination of intangible asset (129,613)
Loss on the sale of Skincare 39,676
Realized loss on sale of investments 371,494
Unrealized gain on investments (238,899)
Changes in operating assets and liabilities:    
Receivables (104,473) 6,958
Prepaid expenses and deposits 120,999 137,295
Inventory 22,966 (482,881)
Accounts payable and accrued liabilities (169,268) 210,111
Customer deposits (20,496) (12,379)
Due to related parties (397,728) 50,306
Cash flows used in operating activities [1] (2,693,714) (3,104,757)
Investing activities    
Purchase of equipment (9,160)
Purchase of investments (995,100)
Proceeds from sale of investments 1,109,921
Issuance of promissory note (127,300)
Purchase of intangible assets (6,000) (112,320)
Cash flows used in investing activities [1] (18,479) (121,480)
Financing activities    
Exercise of Series A warrants 1,938,772
Proceeds from the issuance of common stock and warrants 1,484,028
Share issuance costs (531,290)
Repurchase of shares and warrants (179)
Issuance of common shares under ATM agreement 1,519,437
Cash flows provided by financing activities 4,410,768
Effect of exchange rate changes on cash (400) (580)
Increase(decrease) in cash 1,698,175 (3,226,817)
Cash, beginning of period 3,984,453 3,326,851
Cash, ending of period 5,682,628 100,034
Supplemental cash flow information:    
Cash paid for interest 791 11,104
Cash paid for taxes
Non-cash Investing and Financing transactions:    
Common stock issued and issuable on acquisition of intangible asset 43,535 772,247
Obligation to issue stock for acquisition of intangible assets 838,374
Shares received as proceeds for the sale of Skincare 728,550
Series B preferred shares issues to settle accrued bonus liability 150,000
Consideration payable settled through termination of the agreement $ 894,151
[1] Refer to Note 4 for disclosure of cash flows used in operating and investing activities of discontinued operations.